Sandoz Takes Enbrel Fight To The US Supreme Court

Federal Circuit Decisions Last Year Leave Potential Eight-Year Wait On Etanercept

Sandoz had hinted that further legal action was viable as it looks to introduce biosimilar competition to Amgen’s Enbrel blockbuster in the US. The Novartis subsidiary has now taken its fight to the very highest court.

US-Supreme-Court_V1_1200
Sandoz is seeking US Supreme Court Review of the Fed. Cir.'s 1 July 2020 decision. • Source: Shutterstock

Sandoz is taking one last shot to topple US patents blocking a path for its biosimilar to Amgen’s Enbrel (etanercept), filing a petition with the US Supreme Court for certiorari review of an unfavorable US Court of Appeals for the Federal Circuit decision which upheld the validity of two patents shielding the $5bn autoimmune diseases treatment.

In July last year, the Federal Circuit moved to affirm a New Jersey district court decision that held as valid...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.